• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

激光辅助光动力疗法治疗增殖性疣状口腔白斑病。

Laser-assisted photodynamic therapy in proliferative verrucous oral leukoplakia.

机构信息

State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, Research Unit of Oral Carcinogenesis and Management, Chinese Academy of Medical Sciences, West China Hospital of Stomatology, Sichuan University, Chengdu, Sichuan 610041, PR China.

State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, Research Unit of Oral Carcinogenesis and Management, Chinese Academy of Medical Sciences, West China Hospital of Stomatology, Sichuan University, Chengdu, Sichuan 610041, PR China.

出版信息

Photodiagnosis Photodyn Ther. 2022 Sep;39:103002. doi: 10.1016/j.pdpdt.2022.103002. Epub 2022 Jul 6.

DOI:10.1016/j.pdpdt.2022.103002
PMID:35809828
Abstract

Proliferative verrucous leukoplakia (PVL) is a rapidly progressing, easily relapsed, and cancer-prone oral potential malignant disease (OPMD), for which treatment options are currently limited. Non-invasive photodynamic therapy (PDT) uses specific wavelengths of light to excite photosensitizers and generate reactive oxygen species to induce cytotoxic effects, and it is selective for malignant tissues. However, the lesions of PVL often show hyperkeratosis, which limits the penetration of photosensitizers into the tissue and affects the effectiveness of PDT. Laser, a safe and efficient treatment, has shown great advantages in aiding photosensitizer delivery, due to its ability to accelerate the penetration of 5-aminolevulinic acid (5-ALA) and improve the accumulation of protoporphyrin IX (PPIX) in tissues. In the case report, we achieved complete remission and no recurrence at 8 months in a patient with PVL through laser-assisted PDT, which obtained satisfactory clinical effect and well protected the appearance and function of oral cavity.

摘要

增殖性疣状白斑(PVL)是一种快速进展、易复发且易恶变的口腔潜在恶性疾病(OPMD),目前治疗选择有限。非侵入性光动力疗法(PDT)利用特定波长的光来激发光敏剂并产生活性氧物质,从而诱导细胞毒性作用,对恶性组织具有选择性。然而,PVL 的病变常表现为过度角化,这限制了光敏剂进入组织的渗透,影响了 PDT 的效果。激光作为一种安全有效的治疗方法,由于其能够加速 5-氨基酮戊酸(5-ALA)的渗透并提高组织中原卟啉 IX(PPIX)的积累,在辅助光敏剂输送方面显示出了巨大的优势。在该病例报告中,我们通过激光辅助 PDT 使 PVL 患者在 8 个月时达到完全缓解且无复发,获得了满意的临床效果,并很好地保护了口腔的外观和功能。

相似文献

1
Laser-assisted photodynamic therapy in proliferative verrucous oral leukoplakia.激光辅助光动力疗法治疗增殖性疣状口腔白斑病。
Photodiagnosis Photodyn Ther. 2022 Sep;39:103002. doi: 10.1016/j.pdpdt.2022.103002. Epub 2022 Jul 6.
2
Potential of photodynamic therapy as a minimally invasive treatment for oral verrucous carcinoma.光动力疗法作为一种微创治疗口腔疣状癌的潜力。
Photodiagnosis Photodyn Ther. 2024 Oct;49:104320. doi: 10.1016/j.pdpdt.2024.104320. Epub 2024 Aug 28.
3
Photodynamic therapy combined with laser drilling successfully prevents the recurrence of refractory oral proliferative verrucous leukoplakia.光动力疗法联合激光打孔成功预防难治性口腔增殖性疣状白斑的复发。
Photodiagnosis Photodyn Ther. 2021 Dec;36:102564. doi: 10.1016/j.pdpdt.2021.102564. Epub 2021 Oct 3.
4
Treatment of oral leukoplakia by topical application of 5-aminolevulinic acid.通过局部应用5-氨基酮戊酸治疗口腔白斑病。
Int J Oral Maxillofac Surg. 1998 Dec;27(6):466-9. doi: 10.1016/s0901-5027(98)80040-4.
5
A phase I trial of aminolevulinic acid-photodynamic therapy for treatment of oral leukoplakia.一项氨基酮戊酸光动力疗法治疗口腔白斑的 I 期临床试验。
Oral Oncol. 2013 Sep;49(9):970-976. doi: 10.1016/j.oraloncology.2013.05.011. Epub 2013 Jul 8.
6
Photodynamic therapy (PDT) using topically applied delta-aminolevulinic acid (ALA) for the treatment of oral leukoplakia.使用局部应用δ-氨基乙酰丙酸(ALA)进行光动力疗法(PDT)治疗口腔白斑。
J Oral Pathol Med. 2003 Jul;32(6):330-6. doi: 10.1034/j.1600-0714.2003.00068.x.
7
Plum-blossom needle assisted photodynamic therapy for the treatment of oral potentially malignant disorder in the elderly.梅花针辅助光动力疗法治疗老年口腔潜在恶性疾病。
Photodiagnosis Photodyn Ther. 2019 Mar;25:296-299. doi: 10.1016/j.pdpdt.2019.01.011. Epub 2019 Jan 8.
8
Efficacy of Aminolevulinic Acid Mediated Photodynamic Therapy in the Treatment of Oral Premalignant Lesions: A Systematic Review.基于氨基酮戊酸的光动力疗法治疗口腔癌前病变的疗效:一项系统评价。
Asian Pac J Cancer Prev. 2024 Sep 1;25(9):2971-2978. doi: 10.31557/APJCP.2024.25.9.2971.
9
The combination of photodynamic therapy and fractional CO laser for oral leukoplakia: Case series.光动力疗法联合分次二氧化碳激光治疗口腔白斑:病例系列
Photodiagnosis Photodyn Ther. 2020 Mar;29:101597. doi: 10.1016/j.pdpdt.2019.101597. Epub 2019 Nov 7.
10
Successful treatment of oral verrucous hyperplasia and oral leukoplakia with topical 5-aminolevulinic acid-mediated photodynamic therapy.外用5-氨基酮戊酸介导的光动力疗法成功治疗口腔疣状增生和口腔白斑。
Lasers Surg Med. 2005 Aug;37(2):114-22. doi: 10.1002/lsm.20214.

引用本文的文献

1
Malignant Transformation of Proliferative Verrucous Leukoplakia: A Description of the Clinical Oral Characteristics of These Squamous Cell Carcinomas.增殖性疣状白斑的恶性转化:这些鳞状细胞癌的口腔临床特征描述
Cancers (Basel). 2025 Apr 1;17(7):1199. doi: 10.3390/cancers17071199.
2
Probiotics and prebiotics: new treatment strategies for oral potentially malignant disorders and gastrointestinal precancerous lesions.益生菌与益生元:口腔潜在恶性疾病及胃肠道癌前病变的新治疗策略
NPJ Biofilms Microbiomes. 2025 Apr 8;11(1):55. doi: 10.1038/s41522-025-00688-9.
3
A Bibliometric and Visualised Analysis of Proliferative Verrucous Leucoplakia From 2003 to 2023.
2003年至2023年增殖性疣状白斑的文献计量学与可视化分析
Int Dent J. 2025 Feb;75(1):333-344. doi: 10.1016/j.identj.2024.07.001. Epub 2024 Jul 22.
4
Clinical, histopathological characteristics and malignant transformation of proliferative verrucous leukoplakia with 36 patients: a retrospective longitudinal study.36 例增殖性疣状白斑的临床、组织病理学特征及恶变:一项回顾性纵向研究。
BMC Oral Health. 2024 May 30;24(1):639. doi: 10.1186/s12903-024-04360-0.
5
Clinical evaluation of photodynamic therapy for oral leukoplakia: a retrospective study of 50 patients.临床评价光动力疗法治疗口腔白斑病:50 例回顾性研究。
BMC Oral Health. 2024 Jan 3;24(1):9. doi: 10.1186/s12903-023-03791-5.